European Haemophilia Consortium / X
Jun 30, 2025, 09:41
Eighty People Walk Into Brussels and Leave With Better Policies and a Sharper Lens on Hemophilia: EHC Leadership Conference 2025
The European Haemophilia Consortium recently shared a proud post on X:
”On 26-29 June, 80+ participants gathered in Brussels for our EHC Leadership Conference! Three days of collaboration, learning and strategic discussions. Highlights: welcoming Kazakhstan as our new member, community debates & access to care. See you in Vienna Oct 3-5!”
It was just another ordinary summer weekend — if your idea of “ordinary” includes 80+ advocates, doctors, youth leaders, and policy enthusiasts voluntarily spending three days indoors discussing bleeding disorders.
June 26-29, Brussels: Welcome to the EHC Leadership Conference 2025, where coffee was strong, debates were stronger, and the stakes, as always, involved access to care across an entire continent.
Among the many “EHC moments,” one stood out: Kazakhstan officially joined the family!
Catch the next wave of EHC energy in Vienna, October 3–5.
Stay updates on the World of Hemophilia with Hemostasis Today.
-
Aug 15, 2025, 23:36Irene M Lang's Editorial on Getting Risk Assessment Right in Acute Pulmonary Embolism
-
Aug 15, 2025, 23:31Richard Buka: Many Improvements Needed in HIT Management
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 15, 2025, 23:35SEC61B Mediated Platelet Hyperactivity in People with Diabetes
-
Aug 15, 2025, 23:32Fibrinogen Concentrate Safely Replaces Cryoprecipitate in Neonatal Cardiac Surgery
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
Aug 15, 2025, 23:35
Aug 15, 2025, 23:33
Aug 15, 2025, 23:31
Aug 15, 2025, 14:23
Aug 14, 2025, 23:47
Aug 14, 2025, 23:47